SCHEMBL31235807

SCHEMBL31235807

NCCOCCOCCOCCOCCOCCOCCOCCOCCN(CCOCCOCCOCCOCCOCCOCCOCCOCCN)Cc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 1/20 0.46
PRMT6 Q96LA8 1/20 0.46
PRMT8 Q9NR22 1/20 0.46
ABCB1 P08183 1/20 0.43
TSHR P16473 1/20 0.40
LTA4H P09960 1/20 0.40
OPRM1 P35372 2/20 0.39
OPRD1 P41143 2/20 0.39
OPRK1 P41145 2/20 0.39
TAAR1 Q96RJ0 2/20 0.38
AOC3 Q16853 1/20 0.38
CALM1 P0DP23 1/20 0.38
CAMKK2 Q96RR4 1/20 0.38
CYP2A6 P11509 1/20 0.38
HTR2A P28223 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22735633 0.98 CARM1 (0.47) CARM1PRMT6PRMT8ABCB1TSHR
SCHEMBL22498765 0.96 CARM1 (0.46) CARM1PRMT6PRMT8ABCB1TSHR
SCHEMBL12918861 0.87 TSHR (0.45) ABCB1TSHROPRM1OPRD1OPRK1
SCHEMBL21043434 0.82 CALM1 (0.44) ABCB1TSHRCALM1CAMKK2SMN1; SMN2
SCHEMBL31156713 0.82 HTT (0.51) ABCB1TSHROPRM1OPRD1OPRK1
SCHEMBL24178220 0.82 CALM1 (0.44) ABCB1TSHRCALM1CAMKK2SMN1; SMN2
SCHEMBL24440540 0.82 HTT (0.51) ABCB1TSHROPRM1OPRD1OPRK1
SCHEMBL13406737 0.81 ABCB1 (0.56) ABCB1TSHRLTA4HOPRM1OPRD1
SCHEMBL9302526 0.81 CARM1 (0.68) CARM1PRMT6PRMT8TSHRSMN1; SMN2
SCHEMBL2582068 0.80 ALDH1A1 (0.44) CARM1PRMT6PRMT8SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642484-A1 TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE Hangzhou Seehe Biotechnology Co., Ltd (CN) 2025-11-05 EP disclosed
WO-2024239281-A1 TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) 2024-11-28 WO disclosed